VIENNA (EGMN) - The glucose-lowering drug metformin is increasingly showing an anticancer effect. The data come from studies being conducted in both the diabetes and oncology research communities, according to experts who spoke at the annual meeting of the European Association for the Study of Diabetes. The positive metformin story has been somewhat buried within the much broader and very complicated relationship between diabetes treatments and cancer. The subject first caught the medical community's...